| Impact of inflammation and anti-inflammatory modalities on skeletal muscle healing: from fundamental research to the clinic E Duchesne, SS Dufresne, NA Dumont Physical therapy 97 (8), 807-817, 2017 | 86 | 2017 |
| Monocyte depletion increases local proliferation of macrophage subsets after skeletal muscle injury CH Côté, P Bouchard, N van Rooijen, D Marsolais, E Duchesne BMC Musculoskeletal Disorders 14, 1-11, 2013 | 53 | 2013 |
| A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1 C Gagnon, É Petitclerc, M Kierkegaard, J Mathieu, É Duchesne, LJ Hébert Journal of neurology 265, 1698-1705, 2018 | 44 | 2018 |
| What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review MP Roussel, M Morin, C Gagnon, E Duchesne BMC musculoskeletal disorders 20, 1-14, 2019 | 39 | 2019 |
| Inflammation‐induced leukocyte accumulation in injured skeletal muscle: Role of mast cells CH Côt́e, MH Tremblay, E Duchesne, BM Lapoite Muscle & Nerve: Official Journal of the American Association of …, 2008 | 39 | 2008 |
| Mast cell tryptase stimulates myoblast proliferation; a mechanism relying on protease-activated receptor-2 and cyclooxygenase-2 E Duchesne, MH Tremblay, CH Côté BMC Musculoskeletal Disorders 12, 1-9, 2011 | 37 | 2011 |
| Inflammatory cells do not decrease the ultimate tensile strength of intact tendons in vivo and in vitro: protective role of mechanical loading D Marsolais, É Duchesne, CH Côté, J Frenette Journal of applied physiology 102 (1), 11-17, 2007 | 35 | 2007 |
| A more efficient transportable and scalable system for real-time activities and exercises recognition K Chapron, V Plantevin, F Thullier, K Bouchard, E Duchesne, S Gaboury Sensors 18 (1), 268, 2018 | 29 | 2018 |
| Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1 MP Roussel, LJ Hébert, E Duchesne Neuromuscular Disorders 30 (4), 283-293, 2020 | 28 | 2020 |
| Mast cells can regulate skeletal muscle cell proliferation by multiple mechanisms E Duchesne, P Bouchard, MP Roussel, CH Côté Muscle & nerve 48 (3), 403-414, 2013 | 26 | 2013 |
| Intra-rater reliability and concurrent validity of quantified muscle testing for maximal knee extensors strength in men with myotonic dystrophy type 1 MP Roussel, LJ Hébert, E Duchesne Journal of neuromuscular diseases 6 (2), 233-240, 2019 | 16 | 2019 |
| Effects and acceptability of an individualized home-based 10-week training program in adults with myotonic dystrophy type 1 I Lessard, S Gaboury, C Gagnon, K Bouchard, K Chapron, M Lavoie, ... Journal of neuromuscular diseases 8 (1), 137-149, 2021 | 13 | 2021 |
| MYTHO is a novel regulator of skeletal muscle autophagy and integrity JP Leduc-Gaudet, A Franco-Romero, M Cefis, A Moamer, FE Broering, ... Nature communications 14 (1), 1199, 2023 | 11 | 2023 |
| What is known about muscle strength reference values for adults measured by hand-held dynamometry: a scoping review M Morin, E Duchesne, J Bernier, P Blanchette, D Langlois, LJ Hébert Archives of Rehabilitation Research and Clinical Translation 4 (1), 100172, 2022 | 10 | 2022 |
| Psychometric properties of a standardized protocol of muscle strength assessment by hand-held dynamometry in healthy adults: a reliability study M Morin, LJ Hébert, M Perron, É Petitclerc, SR Lake, E Duchesne BMC Musculoskeletal Disorders 24 (1), 294, 2023 | 7 | 2023 |
| Validity of the Mini‐BESTest in adults with myotonic dystrophy type 1 E Duchesne, LJ Hébert, J Mathieu, I Côté, MP Roussel, C Gagnon Muscle & Nerve 62 (1), 95-102, 2020 | 7 | 2020 |
| Individual transcriptomic response to strength training for patients with myotonic dystrophy type 1 EE Davey, C Légaré, L Planco, S Shaughnessy, CD Lennon, MP Roussel, ... JCI insight 8 (14), 2023 | 5 | 2023 |
| Pharmacological and exercise‐induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients A Ravel‐Chapuis, E Duchesne, BJ Jasmin The Journal of Physiology 600 (14), 3249-3264, 2022 | 5 | 2022 |
| Acti-DM1: monitoring the activity level of people with myotonic dystrophy type 1 through activity and exercise recognition K Chapron, P Lapointe, I Lessard, H Darsmstadt-Belanger, K Bouchard, ... IEEE Access 9, 49960-49973, 2021 | 5 | 2021 |
| Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1 MP Roussel, M Morin, M Girardin, AM Fortin, M Leone, J Mathieu, ... BMC Research Notes 12, 1-6, 2019 | 5 | 2019 |
